Home › Neurologic Diseases › California › Los Angeles
Neurologic Diseases clinical trials in Los Angeles, CA
5 studies for Neurologic Diseases are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Product Surveillance Registry
RecruitingObservational study
- Los Angeles, Los Angeles
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Los Angeles
Rett Syndrome Registry
RecruitingObservational study
- Children's Hospital Los Angeles, Los Angeles
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- Children's Hospital Los Angeles, Los Angeles
- University of Southern California, Los Angeles
MS-ResearchBiomarkerS
RecruitingObservational studyHealthy volunteers welcomeMentions payment for participants
- Cedars-Sinai Medical Center, Los Angeles
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Washington, DC8 studies
- Dallas, TX7 studies
- Orlando, FL7 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- New York City, NY6 studies
- Houston, TX6 studies
- St. Louis, MO6 studies
- San Diego, CA6 studies
- Chicago, IL6 studies
- Pittsburgh, PA5 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.